| Financial Year |
March 31 2023 |
| Monetary Funds |
185,212,477.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,787,621.87 |
| Accounts Receivable |
322,586,678.79 |
| Advances to Suppliers |
6,180,342.02 |
| Other Receivables |
12,632,774.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
356,100,601.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,476,792.66 |
| Total Current Assets |
924,694,075.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
13,857,117.21 |
| Fixed Assetes |
971,309,828.92 |
| Under-construction Projects |
44,199,732.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
96,080,162.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
53,154,449.32 |
| Deferred Income Tax Assets |
15,109,543.32 |
| Other Non-Current Assets |
21,328,333.37 |
| Sub-Total of Non-Current Assets |
1,221,590,825.84 |
| Total Assets |
2,146,284,901.67 |
| Short-Term Loans |
499,732,929.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
361,056,981.82 |
| Accounts Received In Advance |
2,112,116.97 |
| Employee Compensation Payable |
22,339,555.54 |
| Taxes Payable |
3,318,013.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
321,070,339.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,276,366.96 |
| Other Current Liabilities |
8,299,382.57 |
| Sub-Total of Current Liabilities |
1,224,180,906.90 |
| Long-term Loans |
20,524,150.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,718,858.56 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,248,046.03 |
| Total Liabilities |
1,259,428,952.93 |
| Paid-In Capital(Or Share Stock) |
387,280,800.00 |
| Capital Surplus |
39,306,856.64 |
| Surplus Reserve |
109,462,343.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
390,681,920.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
886,855,948.74 |
| Owner's Equity（Stockholder's Equity） |
886,855,948.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,146,284,901.67 |
